Caligan Partners LP Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$1.2T
Holdings
21
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (21 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | LQDALIQUIDIA CORPORATION | 8,118,892 | $280.0B | 23.05% | |
| 2 | ABVXABIVAX SA | 1,451,924 | $195.8B | 16.12% | |
| 3 | MLYSMINERALYS THERAPEUTICS INC | 5,071,054 | $184.0B | 15.15% | Put |
| 4 | RVMDREVOLUTION MEDICINES INC | 1,283,900 | $102.3B | 8.42% | |
| 5 | PCVXVAXCYTE INC | 1,704,815 | $78.7B | 6.48% | |
| 6 | EX9EXELIXIS INC | 1,553,262 | $68.1B | 5.60% | |
| 7 | ADMAADMA BIOLOGICS INC | 3,012,508 | $54.9B | 4.52% | |
| 8 | XENEXENON PHARMACEUTICALS INC | 1,099,365 | $49.3B | 4.06% | Put |
| 9 | INBXINHIBRX BIOSCIENCES INC | 473,565 | $37.4B | 3.08% | Call |
| 10 | TNGXTANGO THERAPEUTICS INC | 3,729,895 | $33.0B | 2.72% | |
| 11 | TYRATYRA BIOSCIENCES INC | 944,257 | $24.8B | 2.04% | |
| 12 | MAZEMAZE THERAPEUTICS INC | 550,191 | $22.8B | 1.88% | |
| 13 | RAPTRAPT THERAPEUTICS INC | 644,400 | $21.8B | 1.80% | |
| 14 | AVTXAVALO THERAPEUTICS INC | 881,533 | $16.0B | 1.32% | |
| 15 | ANIKANIKA THERAPEUTICS INC | 1,435,130 | $13.8B | 1.14% | |
| 16 | VORVOR BIOPHARMA INC | 925,067 | $10.0B | 0.82% | |
| 17 | IVAINVENTIVA SA | 2,000,000 | $9.3B | 0.77% | |
| 18 | VRCAVERRICA PHARMACEUTICALS INC | 923,910 | $7.7B | 0.63% | |
| 19 | AGIOAGIOS PHARMACEUTICALS INC | 90,000 | $2.4B | 0.20% | Call |
| 20 | SPRBSPRUCE BIOSCIENCES INC | 20,514 | $1.8B | 0.15% | |
| 21 | ELDNELEDON PHARMACEUTICALS INC | 555,978 | $839.0M | 0.07% |